News | Patient Positioning Radiation Therapy | September 20, 2019

Aktina Showcases New Radiotherapy Patient Immobilization Solutions at ASTRO 2019

New solutions include cranial head and neck immobilization, thermoplastics and more

Aktina Showcases New Radiotherapy Patient Immobilization Solutions at ASTRO 2019

September 20, 2019 — Aktina Medical introduced several new products at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago. Featured introductions included PositionPro, a new pitch and roll correction-enabled immobilization system for cranial and head and neck radiotherapy treatments, a new line of thermoplastics and a strapless Respiratory Compression Belt.

In addition, Aktina Medical will be showcasing its line of Interlocking Small Field Circular Cones that ensure accurate radiation dosage. The system of lead-based cones with stainless steel sleeves reduces the risk of human error by confirming the installed cone matches the programmed plan before proceeding. Also on display will be the SpiroCheck Duo automated quality assurance system for the Active Breathing Coordinator. The system ensures precise readings to within 1.25 percent and performance in critical radiotherapy planning and treatment.

Aktina’s exhibit at ASTRO 2019 also included the company’s array of non-invasive immobilization solutions including the Memorial Cradle2 for body radiosurgery, SenoView Prone Breast System, Axion 1 Carbon Fiber Breast Board and more.

For more information:

Related Content

Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...
An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

Diagram showing details of the lung screening experiment. Image courtesy of the European Respiratory Society/Benoit Audelan

News | Artificial Intelligence | September 08, 2021
September 8, 2021 — An artificial intell...
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.